Fine Organic Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹15.8K Cr
For FY 2026-27 and 2027-28, revenue growth is expected to be very flat due to full capacity utilization and delays in expansion projects, especially the SEZ plant commissioning. - Growth during this period, if any, will largely be driven by price increases rather than volume growth. - Post FY 2028, meaningful growth is anticipated once the SEZ plant and U.S. FY'27 and FY'28 expected to have very flat top-line growth due to current full-capacity utilization until the SEZ plant is commissioned. - Growth in FY'27-FY'28 will primarily come from price increases, not volume growth. - Post-FY'28, growth is anticipated once SEZ and U.S.
From Fine Organic's Q3 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹5,181
Market Cap
₹15.8K Cr
P/E Ratio
36.1
Revenue Rank
Margin Rank
How does Fine Organic rank in Chemicals & Petrochemicals?
Compare Fine Organic against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Fine Organic — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹625 Cr, net profit ₹117 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →For FY 2026-27 and 2027-28, revenue growth is expected to be very flat due to full capacity utilization and delays in expansion projects, especially the SEZ plant commissioning.
- →Growth during this period, if any, will largely be driven by price increases rather than volume growth.
- →Post FY 2028, meaningful growth is anticipated once the SEZ plant and U.S. plant become operational, enabling capacity expansion.
- →Historical trends show phased growth patterns: periods of capex followed by 1-2 years of strong growth, then flat growth until new capacities are fully utilized.
- →Domestic demand remains stable with no envisaged drop despite inflation.
- →The company is focusing on cautiously scaling up expansion with plans for world-scale U.S. plant phased over three stages.
- →Opportunities in new products and markets (e.g., feed nutrition, palm-based products, Thailand and Malaysia ventures) offer long-term growth potential but commercialization is gradual.
📈 Profitability & Margins
Rank 3- →FY'27 and FY'28 expected to have very flat top-line growth due to current full-capacity utilization until the SEZ plant is commissioned.
- →Growth in FY'27-FY'28 will primarily come from price increases, not volume growth.
- →Post-FY'28, growth is anticipated once SEZ and U.S. plants are commissioned, but exact projections are not provided yet.
- →Sustainable EBITDA margin range is expected to be 18%-20%, based on historical data over the last 10 years.
- →Past peak profit years like 2022-23 are not considered benchmarks due to unusual supply chain advantages.
- →Management is focused on starting new plants rather than projecting revenue or EPS growth at this stage.
- →Operating profits and EPS growth will likely follow plant commissioning and capacity expansion timelines.
🏗️ Capital Expenditure Plans
Yes- →Fine Organic Industries has ongoing and planned capital investments including:
- → - SEZ Plant in India:
- → - Investment of approximately INR 700-750 crores for Phase 1.
- → - Construction recently started; commissioning expected in second half of FY 2028.
- → - U.S. Plant:
- → - Land acquired; contractor finalization in progress.
- → - Planned as a world-scale facility in multiple phases (3 phases planned).
- → - First phase to be conservative in size; commissioning expected within 18-24 months after construction start.
- → - Investment figure to be announced next quarter.
- → - Oleofine Organics Acquisition:
- → - 80% share acquisition completed; current revenue approx INR 54 crores.
- → - Plans underway to expand this palm-based food additives business.
- → - Other Expansion Plans:
- → - Thailand JV expansion planned but delayed due to SEZ focus.
- → - Strategic hiring ongoing to support SEZ and U.S. plant projects.
- → - Expansion delays occurred due to land acquisition issues in Gujarat (Dholera), delaying SEZ by 1-1.5 years.
💰 Fundraising & Capital Structure
No information- →There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company has focused on internal funding for expansions, including equity infusion in subsidiaries (e.g., INR 6.17 crores in Thailand JV, USD 1.12 million in U.S. subsidiary).
- →Capex for the SEZ plant (INR 700-750 crores) and upcoming U.S. plant investment plans are being considered, but no specific details on external fundraising for these are provided.
- →Management is currently finalizing contractor discussions for U.S. plant; investment figures to be announced next quarter.
- →No direct reference to raising funds through debt or equity was mentioned during the Q&A or closing comments.
📋 Order Book & Pipeline
No information- →The company is currently focusing on short-term contracts with customers, especially due to raw material price volatility and supply chain challenges.
- →Long-term contracts are not being entered into at present to remain flexible amid unstable raw material prices; customers are cooperating with shorter contract durations (1-3 months).
- →Existing plants are running at almost full capacity, prioritizing domestic customers and managing export demands accordingly.
- →New capacities such as the SEZ plant and U.S. plant are under construction but not yet commissioned; once operational, they are expected to accommodate incremental demand.
- →The demand situation remains stable despite inflation, with customers expanding operations, and no significant issues in fulfilling orders domestically due to prioritization.
- →No explicit specific figures of the current or expected order book/pending orders have been disclosed in the transcript.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Fine Organic Q3 FY26 results?
For FY 2026-27 and 2027-28, revenue growth is expected to be very flat due to full capacity utilization and delays in expansion projects, especially the SEZ plant commissioning. - Growth during this period, if any, will largely be driven by price increases rather than volume growth. - Post FY 2028, meaningful growth is anticipated once the SEZ plant and U.S. FY'27 and FY'28 expected to have very flat top-line growth due to current full-capacity utilization until the SEZ plant is commissioned. - Growth in FY'27-FY'28 will primarily come from price increases, not volume growth. - Post-FY'28, growth is anticipated once SEZ and U.S.
What is Fine Organic share price analysis?
Fine Organic currently shows a neutral. The stock trades at a P/E of 36.1 with a market cap of ₹15,820 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fine Organic planning capital expenditure?
Fine Organic Industries has ongoing and planned capital investments including: - SEZ Plant in India: - Investment of approximately INR 700-750 crores for Phase 1. - Construction recently started; commissioning expected in second half of FY 2028. - U.S.
Keep Fine Organic on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.